Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 11
Submit an article Journal homepage
471
Views
44
CrossRef citations to date
0
Altmetric
Original Article

Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease

L. Bartorelli Geriatrics Unit, S. Eugenio Hospital, Rome, ItalyCorrespondence[email protected]
,
C. Giraldi Neurology Unit, Campo di Marte Hospital, Lucca, Italy
,
M. Saccardo Department of Neurology, C. Poma Hospital, Mantova, Italy
,
S. Cammarata Alzheimer Evaluation Unit, ‘Struttura Semplice Laboratorio di Neuropsicologia’, Galliera Hospital, Genoa, Italy
,
G. Bottini I Department of Neurology, Niguarda Ca’ Granda Hospital, Milan, Italy
,
A. M. Fasanaro Department of Neurology, A. Cardarelli Hospital, Naples, Italy
,
A. Trequattrini Alzheimer Evaluation Unit, Mental Health Center, Local Health Unit No. 1, Città di Castello (PG), Italy
& for the Upgrade Study Group (members are listed after Acknowledgements) show all
Pages 1809-1817 | Accepted 14 Sep 2005, Published online: 07 Oct 2005

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Adnan Jathlan Al-Rehaily, Saleh Ibrahim Alqasoumi, Hasan Soliman Yusufoglu, Mohammed Abdulaziz Al-Yahya, Betul Demirci, Nurhayat Tabanca, David Earl Wedge, Fatih Demirci, Ulrich Reginald Bernier, James - John Becnel, Halide Edip Temel & Kemal Husnu Can Baser. (2014) Chemical Composition and Biological Activity of Haplophyllum tuberculatum Juss. Essential Oil. Journal of Essential Oil Bearing Plants 17:3, pages 452-459.
Read now
David B Hogan. (2007) Progress update: Pharmacological treatment of Alzheimer’s disease. Neuropsychiatric Disease and Treatment 3:5, pages 569-578.
Read now

Articles from other publishers (42)

Patamawadee Silalai, Suwichada Jaipea, Jiraporn Tocharus, Anan Athipornchai, Apichart Suksamrarn & Rungnapha Saeeng. (2022) New 1,2,3-Triazole-genipin Analogues and Their Anti-Alzheimer’s Activity. ACS Omega 7:28, pages 24302-24316.
Crossref
Ankit Jana, Arkadyuti Bhattacharjee, Sabya Sachi Das, Avani Srivastava, Akshpita Choudhury, Rahul Bhattacharjee, Swagata De, Asma Perveen, Danish Iqbal, Piyush Kumar Gupta, Saurabh Kumar Jha, Shreesh Ojha, Sandeep Kumar Singh, Janne Ruokolainen, Niraj Kumar Jha, Kavindra Kumar Kesari & Ghulam Md Ashraf. (2022) Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease. Molecular Neurobiology 59:6, pages 3512-3528.
Crossref
Feng Zhang, Xinyao Liu, Yufei Liu, Yanjiang Wang & Weidong Le. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 2677 2707 .
Galina F. Makhaeva, Sofya V. Lushchekina, Nadezhda V. Kovaleva, Tatiana Yu. Astakhova, Natalia P. Boltneva, Elena V. Rudakova, Olga G. Serebryakova, Alexey N. Proshin, Igor V. Serkov, Tatiana P. Trofimova, Victor A. Tafeenko, Eugene V. Radchenko, Vladimir A. Palyulin, Vladimir P. Fisenko, Jan Korábečný, Ondrej Soukup & Rudy J. Richardson. (2021) Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment. Bioorganic Chemistry 112, pages 104974.
Crossref
Gabriela Villalta, Melissa Salinas, James Calva, Nicole Bec, Christian Larroque, Giovanni Vidari & Chabaco Armijos. (2021) Selective BuChE Inhibitory Activity, Chemical Composition, and Enantiomeric Content of the Essential Oil from Salvia leucantha Cav. Collected in Ecuador. Plants 10:6, pages 1169.
Crossref
Daniel Schuch da Silva, Mayara Sandrielly Pereira Soares, Fernanda Cardoso Teixeira, Júlia Eisenhardt de Mello, Anita Avila de Souza, Karina Pereira Luduvico, Cinthia Melazzo de Andrade, Roselia Maria Spanevello & Wilson Cunico. (2021) Multitarget Effect of 2-(4-(Methylthio)phenyl)-3-(3-(piperidin-1-yl)propyl)thiazolidin-4-one in a Scopolamine-Induced Amnesic Rat Model. Neurochemical Research 46:6, pages 1554-1566.
Crossref
Galina F. Makhaeva, Nadezhda V. Kovaleva, Elena V. Rudakova, Natalia P. Boltneva, Sofya V. Lushchekina, Irina I. Faingold, Darya A. Poletaeva, Yuliya V. Soldatova, Raisa A. Kotelnikova, Igor V. Serkov, Anatoly K. Ustinov, Alexey N. Proshin, Eugene V. Radchenko, Vladimir A. Palyulin & Rudy J. Richardson. (2020) New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer’s Disease Treatment. Molecules 25:24, pages 5891.
Crossref
Galina F. Makhaeva, Nadezhda V. Kovaleva, Natalia P. Boltneva, Sofya V. Lushchekina, Tatiana Yu. Astakhova, Elena V. Rudakova, Alexey N. Proshin, Igor V. Serkov, Eugene V. Radchenko, Vladimir A. Palyulin, Sergey O. Bachurin & Rudy J. Richardson. (2020) New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer’s Disease Treatment. Molecules 25:17, pages 3915.
Crossref
Galina F. Makhaeva, Nadezhda V. Kovaleva, Natalia P. Boltneva, Sofya V. Lushchekina, Elena V. Rudakova, Tatyana S. Stupina, Alexey A. Terentiev, Igor V. Serkov, Alexey N. Proshin, Eugene V. Radchenko, Vladimir A. Palyulin, Sergey O. Bachurin & Rudy J. Richardson. (2020) Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer’s disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. Bioorganic Chemistry 94, pages 103387.
Crossref
Feng Zhang, Xinyao Liu, Yufei Liu, Yanjiang Wang & Weidong Le. 2019. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 31 .
Jianping Jia, Yong Ji, Tao Feng, Qinyong Ye, Dantao Peng, Weihong Kuang, Yuping Ning, Zhihou Liang, Dongsheng Fan, Wenshi Wei, Yansheng Li & Shifu Xiao. (2019) Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer’s Disease. Journal of Alzheimer's Disease 72:4, pages 1313-1322.
Crossref
Ping Bai, Keren Wang, Pengfei Zhang, Jian Shi, Xinfeng Cheng, Qi Zhang, Cheng Zheng, Yao Cheng, Jian Yang, Xiaoxia Lu & Zhipei Sang. (2019) Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. European Journal of Medicinal Chemistry 183, pages 111737.
Crossref
Supatporn Tepmongkol, Solaphat Hemrungrojn, Patrick Dupont, Chavit Tunvirachaisakul, Daruj Aniwattanapong, Yuttachai Likitjareon, Thitiporn Supasitthumrong, Itthipol Tawankanjanachot, Natakorn Siritranon, Phenphichcha Chuchuen, Buntipa Natsawang & Sookjaroen Tangwongchai. (2019) Early prediction of donepezil cognitive response in Alzheimer’s disease by brain perfusion single photon emission tomography. Brain Imaging and Behavior 13:6, pages 1665-1673.
Crossref
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration 325 357 .
Po-Heng Tsai. (2018) Clinical Management of Episodic Memory Changes in Dementia. Current Treatment Options in Neurology 20:3.
Crossref
Haroon Mehfooz, Aamer Saeed, Anamika Sharma, Fernando Albericio, Fayaz Larik, Farukh Jabeen, Pervaiz Channar & Ulrich Flörke. (2017) Dual Inhibition of AChE and BChE with the C-5 Substituted Derivative of Meldrum’s Acid: Synthesis, Structure Elucidation, and Molecular Docking Studies. Crystals 7:7, pages 211.
Crossref
L.P. Kotra & J. Park. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 439 473 .
Jana Hroudová, Namrata Singh, Zdeněk Fišar & Kallol K. Ghosh. (2016) Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism. European Journal of Medicinal Chemistry 121, pages 774-784.
Crossref
Po-Heng Tsai & Jeffrey L. Cummings. 2016. The Behavioral Neurology of Dementia. The Behavioral Neurology of Dementia 415 424 .
Michela Rosini, Elena Simoni, Roberta Caporaso & Anna Minarini. (2016) Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics. Future Medicinal Chemistry 8:6, pages 697-711.
Crossref
Katsuyoshi Mizukami, Hiroyasu Akatsu, Eric E. Abrahamson, Zhiping Mi & Milos D. Ikonomovic. (2016) Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease. Neuropathology 36:2, pages 135-145.
Crossref
Tae-Young HwangInn-Sook AhnSeonwoo KimDoh Kwan Kim. (2016) Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil. Psychiatry Investigation 13:3, pages 341.
Crossref
Laura Saarelainen, Heidi Taipale, Marjaana Koponen, Antti Tanskanen, Anna-Maija Tolppanen, Jari Tiihonen & Sirpa Hartikainen. (2015) The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer’s Disease. Journal of Alzheimer's Disease 49:3, pages 809-818.
Crossref
Aaron Ritter & Jagan A. Pillai. (2015) Treatment of Vascular Cognitive Impairment. Current Treatment Options in Neurology 17:8.
Crossref
Hugo Pereira, Luísa Custódio, Maria Rodrigues, Carolina de Sousa, Marta Oliveira, Luísa Barreira, Nuno Neng, José Nogueira, Salman Alrokayan, Fouzi Mouffouk, Khalid Abu-Salah, Radhouan Ben-Hamadou & João Varela. (2015) Biological Activities and Chemical Composition of Methanolic Extracts of Selected Autochthonous Microalgae Strains from the Red Sea. Marine Drugs 13:6, pages 3531-3549.
Crossref
Gianfranco Spalletta, Carlo Caltagirone, Alessandro Padovani, Sandro Sorbi, Mahmood Attar, Delia Colombo & Luca Cravello. (2014) Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study. PLoS ONE 9:2, pages e89216.
Crossref
Vinogran Naidoo, David A. Karanian, Subramanian K. Vadivel, Johnathan R. Locklear, JodiAnne T. Wood, Mahmoud Nasr, Pamela Marie P. Quizon, Emily E. Graves, Vidyanand Shukla, Alexandros Makriyannis & Ben A. Bahr. (2012) Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology. Neurotherapeutics 9:4, pages 801-813.
Crossref
Darren Cotterell & Martin Brown. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology 262 277 .
K. Engedal, B. Davis, U. Richarz, J. Han, B. Schäuble & N. Andreasen. (2012) Two galantamine titration regimens in patients switched from donepezil. Acta Neurologica Scandinavica 126:1, pages 37-44.
Crossref
B. Tasso, M. Catto, O. Nicolotti, F. Novelli, M. Tonelli, I. Giangreco, L. Pisani, A. Sparatore, V. Boido, A. Carotti & F. Sparatore. (2011) Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer’s disease. European Journal of Medicinal Chemistry 46:6, pages 2170-2184.
Crossref
Fadi Massoud, Julie Eve Desmarais & Serge Gauthier. (2010) Switching cholinesterase inhibitors in older adults with dementia. International Psychogeriatrics 23:3, pages 372-378.
Crossref
Sazal Patyar, Ajay Prakash & Bikash Medhi. (2011) Dual inhibition: a novel promising pharmacological approach for different disease conditions. Journal of Pharmacy and Pharmacology 63:4, pages 459-471.
Crossref
Martin Steinberg & Constantine G. Lyketsos. 2010. Principles and Practice of Geriatric Psychiatry. Principles and Practice of Geriatric Psychiatry 304 311 .
Jan Korabecny, Kamil Musilek, Ondrej Holas, Jiri Binder, Filip Zemek, Jan Marek, Miroslav Pohanka, Veronika Opletalova, Vlastimil Dohnal & Kamil Kuca. (2010) Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease. Bioorganic & Medicinal Chemistry Letters 20:20, pages 6093-6095.
Crossref
Stefano Rizzo, Manuela Bartolini, Luisa Ceccarini, Lorna Piazzi, Silvia Gobbi, Andrea Cavalli, Maurizio Recanatini, Vincenza Andrisano & Angela Rampa. (2010) Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238. Bioorganic & Medicinal Chemistry 18:5, pages 1749-1760.
Crossref
Bernadette McGuinnessDavid Wilson, Stephen Todd & Peter Passmore. (2009) Effective use of drugs in Alzheimer's disease. Practice Nursing 20:Sup1, pages S11-S14.
Crossref
Narelle Warren, Lenore Manderson & RoseAnne Misajon. 2009. Quality of Life and the Millennium Challenge. Quality of Life and the Millennium Challenge 59 80 .
Stefania Butini, Giuseppe Campiani, Marianna Borriello, Sandra Gemma, Alessandro Panico, Marco Persico, Bruno Catalanotti, Sindu Ros, Margherita Brindisi, Marianna Agnusdei, Isabella Fiorini, Vito Nacci, Ettore Novellino, Tatyana Belinskaya, Ashima Saxena & Caterina Fattorusso. (2008) Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors. Journal of Medicinal Chemistry 51:11, pages 3154-3170.
Crossref
Francesca Cerbai, Maria Grazia Giovannini, Claudia Melani, Albert Enz & Giancarlo Pepeu. (2007) N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: A comparison with donepezil and rivastigmine. European Journal of Pharmacology 572:2-3, pages 142-150.
Crossref
G. Waldemar, B. Dubois, M. Emre, J. Georges, I. G. McKeith, M. Rossor, P. Scheltens, P. Tariska & B. Winblad. (2007) Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology 14:1, pages e1-e26.
Crossref
E. Ch. Wolters. 2006. Oxidative Stress and Neuroprotection. Oxidative Stress and Neuroprotection 31 37 .
G. Waldemar, B. Dubois, M. Emre, J. Georges, I. G. McKeith, M. Rossor, P. Scheltens, P. Tariska & B. Winblad. 2006. European Handbook of Neurological Management. European Handbook of Neurological Management 266 298 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.